{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:16:28Z","timestamp":1776395788980,"version":"3.51.2"},"reference-count":16,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"am","delay-in-days":396,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.07.045","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T13:19:05Z","timestamp":1441977545000},"page":"6878-6883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessing different measures of population-level vaccine protection using a case\u2013control study"],"prefix":"10.1016","volume":"33","author":[{"given":"Mohammad","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ae","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Kanungo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byomkesh","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline L.","family":"Deen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Lena","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas F.","family":"Wierzba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujit K.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipika","family":"Sur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2015.07.045_bib0085","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1473-3099(10)70318-2","article-title":"New approaches to the assessment of vaccine herd protection in trials conducted before licensure","volume":"11","author":"Clemens","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.07.045_bib0090","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1371\/journal.pmed.0040336","article-title":"Controlling endemic cholera with oral vaccines","volume":"4","author":"Longini","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2015.07.045_bib0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/oxfordjournals.aje.a009196","article-title":"Study designs for evaluating different efficacy and effectiveness aspects of vaccines","volume":"146","author":"Halloran","year":"1997","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.045_bib0100","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1996.03530290060038","article-title":"Evaluating new vaccines for developing countries. Efficacy or effectiveness?","volume":"275","author":"Clemens","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.07.045_bib0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.07.045_bib0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2015.07.045_bib0115","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cit009","article-title":"Herd protection by a bivalent-killed-whole-cell oral cholera vaccine in the slums of Kolkata, India","volume":"56","author":"Ali","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2015.07.045_bib0120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.045_bib0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/oxfordjournals.epirev.a017988","article-title":"Use of the case\u2013control approach in vaccine evaluation: efficacy and adverse effects","volume":"21","author":"Rodrigues","year":"1999","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2015.07.045_bib0130","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2015.07.045_bib0135","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, killed whole-cell oral cholera vaccine: results from 3 years of follow up of a cluster-randomized, placebo-controlled trial","volume":"5","author":"Sur","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2015.07.045_bib0140","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.vaccine.2013.12.052","article-title":"Estimation of the herd protection of Haemophilus influenzae type b conjugate vaccine against radiologically confirmed pneumonia in children under 2 years old in Dhaka, Bangladesh","volume":"32","author":"Chen","year":"2014","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2015.07.045_bib0145","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in Guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2015.07.045_bib0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"High-level effectiveness of a mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.07.045_bib0155","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/oxfordjournals.aje.a116382","article-title":"Non-participation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines","volume":"135","author":"Clemens","year":"1992","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.045_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.epirev.a036147","article-title":"Evaluating vaccination effectiveness and vaccine efficacy by means of case\u2013control studies","volume":"16","author":"Comstock","year":"1994","journal-title":"Epidemiol Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:21:46Z","timestamp":1759400506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15010051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":16,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15010051"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing different measures of population-level vaccine protection using a case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}